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Abstract: We explored the feasibility of collecting exhaled breath from a moribund 
gray whale (Eschrichtius robustus) for potential non-invasive health monitoring of 
marine mammals. Biogenic volatile organic compound (VOC) profiling is a relatively 
new field of research, in which the chemical composition of breath is used to non-invasively 
assess the health and physiological processes on-going within an animal or human. In 
this study, two telescopic sampling poles were designed and tested with the primary 
aim of collecting whale breath exhalations (WBEs). Once the WBEs were successfully 
collected, they were immediately transferred onto a stable matrix sorbent through a 
custom manifold system. A total of two large volume WBEs were successfully captured 
and pre-concentrated onto two Tenax
®
-TA traps (one exhalation per trap). The samples were 
then returned to the laboratory where they were analyzed using solid phase micro extraction 
(SPME) and gas chromatography/mass spectrometry (GC/MS). A total of 70 chemicals were 
identified (58 positively identified) in the whale breath samples. These chemicals were also 
matched against a database of VOCs found in humans, and 44% of chemicals found in the 
OPEN ACCESS 
Metabolites 2014, 4 791 
 
 
whale breath are also released by healthy humans. The exhaled gray whale breath showed a 
rich diversity of chemicals, indicating the analysis of whale breath exhalations is a promising 
new field of research. 
Keywords: breath analysis; volatile organic compound (VOC); gas chromatography/mass 
spectrometry (GC/MS); marine mammal; gray whale 
 
1. Introduction 
The chemical content of exhaled breath provides comprehensive information about the metabolic 
state of the subject, regardless of the species [1–11]. Studies on human breath have shown that it 
contains a mixture of volatile organic compounds (VOCs) in the gaseous phase [12], as well as  
non-volatile compounds that occur in small aerosolized droplets [13,14]. To date, 1840 biogenic VOCs 
have been identified in healthy humans [15]. Some of these are physiologically relevant indicators of 
health and disease, such as breath biomarkers indicative of specific bacterial, fungal, and viral respiratory 
infections [16–19], while others are associated with various types of cancer [12,20–26]. Breath 
analysis can also detect the presence of ingested compounds [27], exposure to specific exogenous 
substances from the environment [28,29], and exposure to stressful events [30]. The potential application of 
these measures to cetacean conservation physiology studies could provide information about the state of 
their metabolism through non-invasive monitoring. These studies may also provide an interesting animal 
model for human metabolism by comparing common metabolic markers. 
Large whales produce a ―blow‖ or clouds of mist as they exhale at the surface. A whale breath 
exhalation (WBE) is a mixture of gasses and droplets of condensed respiratory vapor. Researchers 
have realized that blow may represent a valuable, entirely non-invasive, physiological sample that can 
be collected with relative ease [31]. Individual whales may blow several times during a single 
surfacing interval, and it is possible for boats to approach the whale closely during this time interval. 
Recent developments in human breath research [32–34] have accelerated interest in developing this 
novel method for cetaceans. 
Some human breath-sampling methods have been successfully modified for cetaceans, and it is 
important to note that human breath studies have shown that the sampling method can have profound 
effects on the analytical results [35,36]. In humans, inert Tedlar
®
 bags are often used for collection of 
whole breath [37–39], while non-volatile components are often collected via cooling of exhaled breath 
to produce ‗exhaled breath condensate‘ (EBC) [40,41]. Further, volatile compounds can be collected 
with vacuum canisters [42] or sorbent traps [35,43,44]. In one case, blow samples from cetaceans have 
been collected from small trained odontocetes in captivity by holding an inverted tube or other device 
directly over the animal‘s blowhole [45]. Blow droplets have been collected from both humpbacks and 
North Atlantic right whales (NARWs) using a variety of sampling devices attached to long poles 
positioned over the blowholes. Pole-based samplers have included the following: nylon fabric 
suspended across a 15 cm ring or a plastic framework [46]; Petri dishes [47] and a remote-controlled 
helicopter have been used to collect blow droplets on Petri dishes attached to the helicopter skids [48]. 
These techniques vary in the sampling volume, sampling rates, and types of information captured. For 
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instance, the nylon sampler is likely to capture non-volatile compounds and mucus. The Petri dishes 
culture microorganisms for potential infectious disease diagnostics, yet it is sometimes difficult to 
attribute the cultured microorganisms to the cetacean respiratory tract. However, together these studies 
demonstrate that routine blow droplet collection from large whales is feasible. To our knowledge, 
direct analysis of exhaled respiratory gasses and VOCs in cetacean breath has not been attempted in 
previous studies. No sampling technique has focused on monitoring cetacean health in the field.  
Two gray whales (Eschrichtius robustus), a mother with her calf, traveled 7 km up the Klamath 
River (Northern California, USA) in June, 2011, during their northward journey from breeding ground 
in Baja California to Alaska. Different attempts to encourage the whales to return to the sea were 
attempted, which included a variety of methods including playing calls of killer whales. After three 
weeks, the calf made it back to the Pacific Ocean, while the mother whale remained in the river. It is 
believed the calf was mature enough (4.5 m) to survive its journey to Alaska. The mother whale (13.7 m 
and 36,000 kg) died on 16 August after beaching on a sandbar in the river. Necropsy results indicated that 
the adult female gray whale died from septicemia presumed secondary to skin infection [49]. 
While researchers and wildlife officials were monitoring the whale in the river and attempting to 
return the female to the ocean, indirect measures such as measuring blow rate, movement patterns and 
collecting sequential photographs to document changing condition of the whale were being collected. 
The purpose of these measurements was not for the direct assessments of the whale‘s health status. Our 
group was invited to collect breath for analysis from the animal, and a field trial was conducted 
between 31 July to 2 August, 2011, at the Klamath River Bridge, on Redwood Highway 101 (towards 
Crescent City, CA). The goal was to collect WBE samples from the adult female gray whale as non-
invasively as possible and examine the feasibility of determining the whale breath metabolic content 
without direct contact with the animal. Figure 1 shows the exhaled blow of the mother gray whale 
while swimming in the Klamath River. 
Figure 1. The adult female gray whale exhales respiratory vapor samples (―blow‖) while 
swimming in the Klamath River. Printed with permission [50]. 
 
2. Methods and Materials 
2.1. Fabrication of WBE Sample Collection System 
A 7 m fiberglass sampling pole was designed and fabricated with a focus aperture to channel the 
WBEs into an inert large volume sampling bag intended to capture whale breath and contain it for 
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further analysis (Figure 2). A 30 L capacity sample bag (Ingeniven LLC; Hampton, NH, UK), 
composed of Teflon
®
, was attached to one end of the pole. This was chosen to minimize potential 
background contamination. This bag material has significant inertness for short-term storage of the 
WBEs prior to transferring the breath chemicals onto a more stable sorbent matrix for ground transport 
and subsequent chemical analysis back in the laboratory. The materials also have the structural 
strength to withstand the force of rapid exhalations by the whale.  
The telescopic sampling pole was originally designed to collect WBEs from humpback whales in 
the open ocean by rotating the pole in a semi-stationary manner with an O-lock interface on the deck 
of a large research vessel. During our field test, we observed the fiberglass pole generated significant 
drag due to our vessel moving at a relatively moderate speed on the water. This combined with the 
relatively narrow channel of the Klamath River with shallow banks made the sampling procedure more 
challenging than anticipated. Modifications of our sampling approach were needed, and the fiberglass 
pole was determined to be unsuitable for our small boat without an O-lock interface for positioning 
and collection. A second lighter sampling pole was designed and fabricated from bamboo (Figure 3a). 
This pole could be easily positioned by only one person, and it had greater flexibility for use with the 
boat. The same sampling bag was used for both sampling poles (30 L) to enable the collection of as 
much sample volume from the whale‘s exhalations as possible. 
Figure 2. Schematic layout of the initial sampling pole showing the individual components. 
 
2.2. Field Sampling Methodology 
Due to the field constraints of the Klamath River environment where the whale was located, a small 
single engine motor boat operated at low speed was used to sample the blow of the gray whale (Figure 3b). 
Exhaled breath samples were collected only when the calf was not nearby the mother gray whale, to ensure 
we did not interfere with their interactions. The sampling pole and collection bag were positioned vertically 
above the blow hole to collect the WBEs directly as the whale was exhaling. This proved to be challenging, 
as the gray whale was continuously moving. The experienced boat operator was able to reposition the boat to 
match the whale‘s movements allowing the correct positioning of the sample collection equipment above 
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the blowhole. Through this process, we successfully sampled two WBEs that were stored for off-site 
analysis of VOCs. 
Figure 3. (a) Lighter bamboo sampling pole with the Teflon bag attach to one end. (b) Method 
used to collect breath from the gray whale in the Klamath River. Printed with permission [51]. 
 
2.3. Stabilization of Breath Gasses for Ground Transport 
Breath gas samples can be extremely unstable over time and the chemicals can easily degrade if not 
stored properly. They also potentially contain VOC signatures associated with the ambient environment. 
Once a breath sample was successfully collected, it was immediately transferred and pre-concentrated 
onto a hydrophobic Tenax
®
-TA sorbent trap and capped with Swagelock
TM
 fittings. This provided an 
extended duration when the samples were stable and could be transported with minimal contamination 
or degradation. The dominat component of whale exhaled breath is water and the effect of condensation 
and resulting potential loss will play a significant role if the sample remains in the bag for an extended 
amount of time. Individually pre-cleaned bags were used for each sample and were not reused 
afterward to minimiz artifact effects. In addition, field sample blanks were also collected and pre-concentrated 
onto a separate Tenax
®
-TA trap before the WBEs were collected. Sample blanks are needed for assessment 
of potential background chemical levels present in the ambient air during the field sampling. Direct 
SPME infield sampling attached to the pole was not considered as we could not ensure the cleanliness 
of the SPME fiber upon storage, transport and sampling. Therefore, we decided to attach a Teflon
®
 bag 
to the sample pole and immediately transfer the obtained exhaled breath to a hydrophobic Tenax
®
-TA 
sorbent to collect the breath biomarkers for short time shortage and transport. Furthermore, the Tenax-
TA sorbent is more suited for the trapping of volatile compounds rather than the non-volatile 
components of breath profiles. 
Each Tenax
®
-TA trap was housed in a quartz wide bore gas chromatograph (GC) liner containing 
200 mg (±4 mg) of Tenax
®
-TA sorbent (mesh size 60/80, Sigma Aldrich, St. Louis, MO, USA). The 
traps were conditioned in replicates (n = 3) using a custom machined aluminum heating block with 
Swagelock
TM
 connections. The manifold was purged with nitrogen at rate of 50 mL/min at 300 °C for 
6 h. This conditioning process within inert atmosphere purged residual compounds remaining on the 
sorbent, and provided a ―blank‖ substrate to trap biologically relevant exhaled breath compounds for 
analysis. Once conditioned, the traps were then allowed to cool for an additional hour prior to being 
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removed and tightly capped with prebaked Swagelock
TM
 fittings and corresponding blanking nuts, 
similar to a commercial thermal desorption tube. A third of our conditioned Tenax
®
-TA traps were 
analyzed to check for artifacts and background levels of exogenous compounds.  
To transfer the WBE sample into the trap, the inlet end of the GC liner was connected to a 200 
mL/min flow regulator to meter the gas flow through the trap to ensure reproducibility. The typical 
transference time from the sampling to the sorbents is 20–30 min. Within the sampling, approximately 
1/4 to 1/5 of the effective 30 L volume was successfully used for collection. The initial (60 s) portion 
of sampling was not collected and was used to purge the flow manifold. The end of the flow meter was 
then carefully inserted into the Teflon
®
 bag containing the whale‘s breath. A tight seal was created on 
the exterior of the bag using multiple layers of PTFE tape and cable ties to ensure minimal whale 
breath gasses escaped from the bag during transfer. A flow regulator was connected such that constant 
pressure was applied to the sampling bag, forcing the WBE through the regulator and the GC liner. 
The breath was transferred directly onto the sorbent trap in the field for both WBE and air blanks. 
Then they were returned to the UC Davis campus for biochemical analysis. 
2.4. Chemical Analysis of the WBE 
SPME fibers of 75 µm thickness PDMS/CAR black coating (Sigma Aldrich, St. Louis, MO, USA) 
were used to introduce the breath gas sample into the gas chromatography/mass spectrometer 
(GC/MS). These fibers were conditioned at 300 °C for 1 h on the auto sampler heater block prior to 
being used, and were periodically analyzed to check for artifacts and contaminations. Each individual 
Tenax
®
-TA sorbent trap was transferred into a clean prebaked 2 mL borosilicate vial and capped. The 
vials were then purged with ultra-high purity nitrogen 99.9995% (Airgas; Sacramento, CA, USA) at 10 
mL/min for 5 min to ensure all oxygen was excavated from the vial prior to heating in order minimize 
any uncontrolled oxidation reactions with whale breath metabolites that could be released from the 
sorbent. The vials were then placed onto a hot plate (pre-heated to 280 °C) for 3 min. The vials were 
subsequently removed from the plate, and one clean SPME fiber was inserted into the vial and left 
exposed for 15 min to collect any biogenic VOCs that thermally desorbed from the Tenax
®
-TA and onto 
the SPME fiber.  
The SPMEs were analyzed with a Varian 4000 Gas Chromatograph / Mass Spectrometer (GC/MS) 
(Agilent; Santa Clara, CA, USA) with a CombiPAL auto sampler system (CTC Analytics; VA, USA) 
and a liquid nitrogen cooling system for low temperature GC/MS analysis. The analytical column was 
a Factor Four VF5ms 30 M × 0.25 mm with a film thickness of 0.25 µm. The GC profile was: initial 
temperature 0 °C hold for 20 min; then ramp at 1 °C/min to 75 °C (hold for 15 min); then ramp to 100 °C 
(hold for 15 min); then ramp at 5 °C/min to 125 °C (hold for 5 min); then ramp at 5 °C to 150 °C; and 
finally ramp at 5 °C/min to 200 °C. 
2.5. Data Analysis and Interpretation 
Data analysis and mass spectral interpretations were carried out on the instrument vendor software [52] 
and automated mass spectral de-convolution and identification system (AMDIS) with medium 
resolution and high sensitivity and shape requirements. MS matching was performed using NIST 05 
databases. By comparing the field sample blank to the WBEs, any peaks that appear in the field sample 
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blank and the WBE samples can be effectively disregarded, as they likely came from the background or 
from impurities introduced during the sample transfer steps rather than of anything of biological 
significance. Only peaks that appeared in the WBEs sample were considered. 
3. Results and Discussion 
The sampling procedure applied in the collections of WBEs demonstrate good signal intensity and 
high signal-to-noise ratio with over 150 chemicals observed in the raw GC/MS spectra. A chromatograph 
of the whale exhalation and an air blanks are shown (Figure 4). The background blanks were used to 
identify and remove contamination/artifacts. In total, 70 chemicals were identified as unique to the 
WBE. Of those chemicals, 58 were identified to come from the whale breath itself and from those 25 
were successfully identified through mass spectral matching with NIST05 (compounds with + in Table 1). 
The peak IDs, retention times (RT), fragmentation patterns, potential matches and additional metadata 
are shown (Table 1). Forward match (match in Table 1) is the similarity of the fragmentation profile from 
low to high mass-to-charge ratio m/z values, whereas the reverse match score is the similarity of the 
fragmentation profile from high to low m/z values. The total match score is the average of the two. The 
CAS number and NIST ID are also provided in Table 1. Many of the compounds identified also match 
with biogenic VOCs that have been identified in healthy humans [15]. From the 70 identified compounds, 
31 of them (44%) were found to be also present in healthy human volatiles. 
Figure 4. GC/MS chromatogram of the exhaled whale breath (top) and the sample blank 
(bottom). In addition, the main regions of interest (regions with most of the relevant VOC‘s) 
are indicated. 
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Table 1. Compounds identified in the moribund gray whale breath by GC/MS. Reported 
are the peak number, retention time (RT), chemical name, CAS number, forward match 
(Match), reverse match (R. Match), relative abundance (RA), chemical formula, molecular 
weight (MW), the NIST identification number and the Human volatile organic compound 
(VOC) Reference when available: Feces (F), urine (U), breath (Br), skin secretions (Sk), 
milk (M), blood (Bl) and saliva (Sa). Compounds successfully identified based on spectral 
library match are shown with a + after the RT value. 
RT 
(min) 
Chemical Name CAS Match R. Match 
RA 
(%) 
Formula MW NIST 
Human 
VOC Ref. 
1.477+ Carbon dioxide 124-38-9 682 696 2.32 CO2 44 18873 F, Br, Bl 
1.549 Carbonyl sulfide 463-58-1 943 952 0.06 COS 60 19006 Br, M 
2.592 Guanidine 113-00-8 811 831 4.98 CH5N3 59 221220  
2.668 Furan 110-00-9 758 767 0.59 C4H4O 68 228308 U, Br, M 
2.960+ 
Cyclopropane,  
1,1-dimethyl- 
1630-94-0 899 899 0.21 C5H10 70 34618  
3.191+ Carbon disulfide 75-15-0  783 785 100.00 CS2 76 118705 
F, U, Br, 
Sk, M 
3.360 2-Propanol, 2-methyl- 75-65-0 796 809 0.34 C4H10O 74 19162 Br, M, Bl 
3.999+ Butane, 2,3-dimethyl- 79-29-8 849 855 0.44 C6H14 86 291518 Br 
4.129+ Octane 111-65-9 847 850 0.95 C8H18 114 229407 
F, Br, Sk, 
Sa 
4.507 2,3-Dihydrofuran 1191-99-7 783 849 4.37 C4H6O 70 114595 F, Br 
4.635 Pentane, 2,3-dimethyl- 565-59-3 756 757 4.15 C7H16 100 61339 Br 
6.643+ Pentane, 2,2-dimethyl- 590-35-2 852 876 12.01 C7H16 100 114486 Br 
6.867+ 2,4,6-Trimethyl-3-heptene 126690-66-2 721 765 1.51 C10H20 140 113569  
9.417 non-ID    15.60     
15.017+ Methane, dibromo- 74-95-3 928 928 3.64 CH2Br2 172 118720 Bl 
27.312+ Toluene 108-88-3 917 917 0.00 C7H8 92 227551 
F, U, Br, 
Sk, M, Bl, 
Sa 
31.912 2-Butene, 2-methyl- 513-35-9 808 808 0.47 C5H10 70 242 Br 
36.689 non-ID    0.15     
47.926+ o-Xylene 95-47-6 879 879 0.49 C8H10 106 228061 
F, Br, M, 
Bl, Sa 
51.064 non-ID    0.84     
51.844+ Ethylbenzene 100-41-4 670 798 0.14 C8H10 106 114918 
F, U, Br, 
Sk, M, Bl 
54.970 Decane 124-18-5 816 816 1.04 C10H22 142 227682 
F, Br, Sk, 
Sa 
56.087+ Ethanol, 2-butoxy- 111-76-2 834 834 0.39 C6H14O2 118 11812 U, Br 
57.765 non-ID    12.19     
64.212 
Benzene,  
(1-methylethyl)- 
98-82-8 920 920 0.05 C9H12 120 114201 F, Br 
64.494+ 
Ethanone,  
2,2-dihydroxy-1-phenyl- 
1075-06-5 874 894 0.18 C8H8O3 152 289212 F 
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Table 1. Cont. 
RT 
(min) 
Chemical Name CAS Match R. Match 
RA 
(%) 
Formula MW NIST 
Human 
VOC Ref. 
65.635 
Benzene,  
1,2,3-trimethyl- 
526-73-8 719 843 7.33 C9H12 120 125395 F, Br, M 
70.597+ Indane 496-11-7 618 780 0.63 C9H10 118 20399 F, Br 
70.931 3-Aminopyridine 462-08-8 671 692 0.06 C5H6N2 94 288371 Sk 
72.982 non-ID    6.15     
73.547 
Benzene, 1-ethyl-4-
methyl- 
622-96-8 772 827 1.19 C9H12 120 114034 F, Br, M 
74.159+ 
Butane, 2-methoxy-2-
methyl- 
994-05-8 690 700 0.87 C6H14O 102 61443  
74.776+ 
Benzene, 1-methyl-4-
(1-methylethyl)- 
99-87-6 911 920 9.71 C10H14 134 113988 
U, Br, Sk, 
Sa 
75.411+ Limonene 138-86-3 764 805 6.13 C10H16 136 57640 
F, U, Br, 
M, Sa 
77.196 1-Hexene, 3,5-dimethyl- 7423-69-0  630 739 2.04 C8H16 112 113470  
77.392+ Benzyl Alcohol 100-51-6 827 891 3.18 C7H8O 108 291348 
F, U, Br, 
Sk, Sa 
78.631 
1-Butanol, 4-(1-
methylethoxy)- 
31600-69-8 768 800 0.20 C7H16O2 132 46521  
78.888 
Benzene, 1-methyl-3-
propyl- 
1074-43-7 573 781 5.70 C10H14 134 57774  
79.357+ 
2(3H)-Furanone, 
dihydro-4-methyl- 
1679-49-8 772 833 0.60 C5H8O2 100 153216  
80.062 non-ID    0.62     
81.189+ Benzoyl bromide 618-32-6 916 916 0.43 C7H5BrO 184 228984  
81.875 
2-Butene-1,4-diol, 
diformate 
29619-56-5 809 818 3.27 C6H8O4 144 4155  
82.071 
Hexanoic acid,  
2-tetrahydrofurylmethyl 
ester 
2217-34-7 684 772 3.03 C11H20O3 200 279279  
82.594+ 
Benzene, 2-ethyl-1,3-
dimethyl- 
2870-04-4 825 830 0.73 C10H14 134 3144  
84.652 non-ID    0.30     
85.086+ 
Benzene, (2-methyl-1-
propenyl)- 
768-49-0 891 891 0.19 C10H12 132 113562 Br 
85.722 
2-Propen-1-one,  
1-phenyl- 
768-03-6 518 618 17.49 C9H8O 132 161642  
86.131 
1-Propanol, 3-chloro-, 
acetate 
628-09-1 633 699 0.27 
C5H9ClO
2 
136 3424  
87.499 
Oxalic acid, isobutyl 
nonyl ester 
- 723 826 2.50 C15H28O4 272 309374  
88.330 1-Hepten-4-ol 3521-91-3 648 704 1.43 C7H14O 114 1768  
88.601 non-ID    4.26     
88.876 non-ID    0.09     
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Table 1. Cont. 
RT 
(min) 
Chemical Name CAS Match R. Match 
RA 
(%) 
Formula MW NIST 
Human 
VOC Ref. 
89.313 2-Ethylpiperidine 1484-80-6 770 783 0.38 C7H15N 113 231734 Sk 
91.945 4-Heptanol 589-55-9 687 785 1.37 C7H16O 116 1897  
93.000 1-Butanol, 4-butoxy- 4161-24-4 804 810 2.19 C8H18O2 146 21344  
96.432 
2-Allyl-2-methyl-1, 
3-cyclopentanedione 
26828-48-8 632 689 6.79 C9H12O2 152 108207  
97.644+ Naphthalene 91-20-3  915 919 3.98 C10H8 128 228342 
F, Br, Sk, 
M, Sa 
97.914 non-ID    4.20     
98.380 
Cyclopentane, 1-
isobutylidene-3-methyl- 
- 664 717 0.20 C10H18 138 150621  
99.099 
o-Toluic acid,  
4-nitrophenyl ester 
- 751 895 0.50 C14H11NO4 257 307460  
99.913 non-ID    1.28     
100.077 
Benzoic acid,  
3-amino-, methyl ester 
4518-10-9 644 654 0.48 C8H9NO2 151 73503  
102.217 2-Butene, 2-nitro- 4812-23-1 596 690 0.06 C4H7NO2 101 75242  
103.393 
Oxalic acid, isobutyl 
octyl ester 
- 788 788 2.98 C14H26O4 258 309373  
103.528 
2-Propenoic acid,  
2-hydroxyethyl ester 
818-61-1 483 733 0.59 C5H8O3 116 71287  
104.608+ 1,9-Nonanediol 3937-56-2 769 769 0.99 C9H20O2 160 114694  
105.468+ Benzothiazole 95-16-9 827 889 0.09 C7H5NS 135 228674 Br, Sk 
106.168 Ethanol, 2-phenoxy- 122-99-6 820 861 1.68 C8H10O2 138 250161 
F, Br, Sk, 
Sa 
107.094 2-Naphthalenol 135-19-3 784 867 3.69 C10H8O 144 92317  
107.739 non-ID    0.78      
The inclusion of the field sample blank aided greatly in identifying artifacts from background or 
impurities induced during sample transfer between different sorbent. We were able to detect a large 
variety of small molecular weight chemicals compounds within the WBEs consistent with the properties of 
VOCs ranging from small short chain hydrocarbons to long branched aliphatic and aromatics, ketones, 
esters, a significant amount of benzoid and halogenated compounds. All MS matching of the tentative 
ID peaks are supplied within the supplementary information section. 
The relative composition of the various classes detected within the whale exhalation is visually 
represented in Table 1 and Figure 5. Below is a brief summary of the compounds detected across various 
chemical classes and tentatively matched within the exhaled whale breath. Alcohols: ethanol, 2-butoxy-; 
benzyl alcohol and 1,9-nonanediol. Short chain aliphatic: carbon dioxide; cyclopropane, 1,1-dimethyl-; 
butane, 2,3-dimethyl-; octane and pentane, 2,2-dimethyl-. Aromatic hydrocarbons: indane, toluene and 
o-xylene. Halogenated hydrocarbons: methane, dibromo- and benzoyl bromide. Benzenoid compounds: 
ethylbenzene; benzene, 1-methyl-4-(1-methylethyl)-; benzene, 2-ethyl-1, 3-dimethyl- and benzene,  
(2-methyl-1-propenyl)-. Esters: ethanone, 2,2-dihydroxy-1-phenyl- and 2(3H)-furanone, dihydro-4-
methyl-. Polycyclic aromatic hydrocarbons (PAH): naphthalene. Substituted alkane and alkenes: 
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2,4,6-trimethyl-3-heptene and butane, 2-methoxy-2-methyl-. Sulfanated compounds: benzothiazole and 
carbon disulphide. Terpenes: limonene. 
Figure 5. Relative abundance for chemical classes of the identified chemicals in the 
moribund gray whale breath exhalations (WBEs). 
 
A variety of chemical compound classes were detected within the WBEs. We should mention that 
the necessary post-collection and transfer steps for chemical analysis needed in this pilot study may 
have caused some sample loss during transfer and a more extended list of detected compounds may be 
expected in future studies.  
Of the detected compounds listed above, a large number of them have been previously reported in 
human clinical studies. In particular, a variety of alcohol biomarkers have been proposed in the 
literature [15]: 2-butoxy-ethanol; benzyl alcohol. In addition, aliphatic hydrocarbons have also been 
reported in humans [15]: carbon dioxide; butane, 2,3-dimethyl-; octane; and pentane, 2,2-dimethyl-. 
Also, aromatic hydrocarbons have been reported in humans [15]: indane, toluene and o-xylene. 
Similarly the halogenated hydrocarbon methane, dibromo- has been reported. The benzenoid 
compounds detected within this study have been reported across multiple biological matrices such a 
breath, skin, saliva, blood, urine and fecal matter [15]. The polycyclic aromatic hydrocarbon (PAH) 
Naphthalene has also been reported [15]. Additionally, the sulfanated compounds are present in 
humans [15]: benzothiazole and carbon disulphide. The identified terpene limonene has also been 
reported [15]. Furthermore, none of the esters or substituted alkane and alkenes have been found in the 
literature to be an endogenous compound and/or biomarkers in human breath. 
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In the whale breath exhalation, some of the expected VOCs that are identified in human exhaled 
breath such as acetone and isoprene are not found. We believe that it is due to the fact that these low 
mass compounds are dispersed more readily than compounds with higher molecular weight. Also, the 
sampling methodology was not optimized and due to the nature of the sampling technique (constrained 
in a river and in a moving boat) not all of the whale breath exhalation might have been collected. 
Therefore, we may miss sampling some of the more volatile components of the exhaled profile due to 
these constraints. 
Certain identified compounds are rather reactive and unstable, such as cyclopropane, 1,1-dimethyl-, 
while others are not really volatile like guanidine. In the supplementary information, we have specified 
the MS matching for all compounds, and the fragmentation patterns of those specific chemical peaks 
are consistent with the putatively matched identification. For unambiguous chemical identification, the 
next step is to run chemical standards and create a MS annotation library. This is a critical procedure to 
ensure the utility of this method for marine mammal health monitoring. 
There are two prior reports to the International Whaling Commission (IWC) of volatile organic 
compound analysis from whale blubber that focuses on both naturally occurring and potential 
contamination chemicals [53,54]. Russian aboriginal people have long observed that certain whales 
hunted for food have ―stinky‖ odorous breath, and this whale meat is inedible. We compared the 
chemicals observed in the Klamath River whale to those reported to the IWC. Out of all of the 
compounds identified in our study, we found that only toluene and naphtalene are reported in the 
stinky gray whale‘s tissue [53]. These compounds might be related to naturally derived metabolites 
from the gray whale as they can be present in healthy human breath, or they may be the breakdown 
products of other metabolites. They may also be environmental contaminants. None of the specific 
compounds reported in the literature for the characteristic ―stinky‖ whale odor were found in the adult 
female gray whale in our study. 
From our current study no health status can be provided for the moribund adult female gray whale; 
however, this study has shown feasibility and potential significance for future marine mammal breath 
biomarker discovery. For future works, if a significant amount of sample from different whales can be 
obtained, the analysis could be focused on levels of starvation to see if whales are metabolizing 
proteins from the muscles, or if there are any indications of the presence of pathogens. 
VOC sampling is regarded as one of more difficult forms of sampling within analytical science. The 
analytes of interest are present in gaseous phase, exposed to oxidizing atmospheres and are often 
partially contaminated with ambient air. All of this can result in highly variable composition from 
sample to sample. In such cases where VOC analysis does not prove to be useful, this method of collecting 
WBEs still has the potential to be an incredibly important addition to the analysis of non-volatile 
breath biomarkers. The sampling approach is simple and relatively low cost, and has the potential to be 
scaled and implemented for marine mammal conservation research in the field. Other more sophisticated 
approaches, such as active sampling of exhale breath condensate (EBC) and non-volatile biomarkers 
could be possible for field trials with smaller cetaceans in capture and release exercises. However, 
those methods are not yet feasible for large marine mammals such as the gray whale or in field trials at 
sea with minimal laboratory support. Nevertheless, our approach has shown to be suitable for obtaining 
meaningful biogenic VOCs from gray whale breath exhalations. 
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4. Conclusions 
We demonstrate that breath VOC analysis may offer a promising avenue of research for large 
marine mammals. The whale breath samples that we collected and analyzed displayed a large number 
of diverse chemical biomarker compounds across multiple classes, which could well provide an indirect 
means of health assessment and monitoring in these large animals. While we collected only a relatively 
limited number of samples in this study, the primary aims of this field trial were to: (1) assess the 
feasibility of collecting whale breath exhalates (WBEs) and identify any potential problems associated 
with this approach; and (2) assess if are there any putative biogenic VOC biomarkers present within 
the WBEs and, if so, assess the relative composition and abundance of these chemicals. We also note 
that a significant portion of the tentatively matched whale breath VOCs was also reported within the 
human clinical trial literature. This study is to our knowledge the first attempt to profile and characterize 
biogenic VOCs collected from free ranging large marine mammals such as gray whales in the field. 
The simplicity of our sampling approach is offset by the complexity of the post-collection and transfer 
steps for chemical analysis, including the transfer from the sampling bag to the Tenax
®
-TA and then to 
SPME for introduction to GC/MS for chemical analysis. While this worked in our pilot study, it may 
result in some loss of sample. However, it was necessary to make the sample stable for storage and 
transport back to the laboratory for subsequent analysis using our equipment. In the future, it would be 
better to simplify sample transfer and reduce the total number of transfer steps. 
Some other suggestions for future studies include:  
(1) Use a thermal desorption (TD) tube to directly introduce the breath sample into the mass 
spectrometer instrument with minimal sample loss. The TD tube is considered a gold standard 
in active VOC sampling practice, especially in outdoor environments. However, this is an 
expensive option as significant equipment investment in consumables and infrastructure is 
required. In addition to the thermal desorption unit, reusable silicone coated stainless steel 
tubes are also available, which include Tenax
®
-TA packing. These devices must also be 
conditioned. TD requires large quantity of ultra-high purity purging gas for conditioning and 
cleaning cycles of sorbent packing between uses. Lastly, the sorbent needs to be replaced 
periodically to ensure maximum absorption capacity as it is only stable for a limited period of 
time after cleaning, even when properly stored in optimal conditions.  
(2) Use a mobile gas detection system to detect specific compounds directly from the whale blow 
in the field. For example, differential mobility spectrometry (DMS) is a portable sensor 
platform currently applied in our group to directly analyze human exhaled breath, and it represents 
an alternative to traditional GC/MS lab based instrument testing. However the spectral resolution of 
DMS is lower compared to MS, but it should still able to generate information rich spectral 
profiles in near real time (5–15 min) for the different chemical species present in the WBE.  
(3) Once further testing is performed on exhaled cetacean breath, it should be possible to develop a 
mass spectral library and database for biogenic breath biomarkers from these marine mammals. 
This is not limited to MS alone, and other VOC sampling and analysis techniques such as DMS 
should be considered. It would also be useful to perform tandem MS/MS for chemical 
identification of the profiled breath metabolites. All of these approaches will help us to 
characterize unidentified biomarkers that may be associated with heath status in these 
important animals. 
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